Microbiological, Epidemiological, and Clinical Characteristics and Outcomes of Patients with Cryptococcosis in Taiwan, 1997–2010

Cryptococcus gattii: An Emerging Fungal Pathogen in the Southeastern United States

(2012) Brenda Sellers et al.   AMERICAN JOURNAL OF THE MEDICAL SCIENCES

Cryptococcus neoformans-Cryptococcus gattii Species Complex: an International Study of Wild-Type Susceptibility Endpoint Distributions and Epidemiological Cutoff Values for Amphotericin B and Flucytosine

(2012) A. Espinel-Ingroff et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Cryptococcus neoformans-Cryptococcus gattii Species Complex: an International Study of Wild-Type Susceptibility Endpoint Distributions and Epidemiological Cutoff Values for Fluconazole, Itraconazole, Posaconazole, and Voriconazole

(2012) A. Espinel-Ingroff et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Cryptococcus gattii: where do we go from here?

(2012) Julie Harris et al.   MEDICAL MYCOLOGY

Involvement of PDK1, PKC and TOR signalling pathways in basal fluconazole tolerance in Cryptococcus neoformans

(2012) Hyeseung Lee et al.   MOLECULAR MICROBIOLOGY

Cryptococcosis in China (1985–2010): Review of Cases from Chinese Database

(2011) Chen Yuchong et al.   MYCOPATHOLOGIA

Cryptococcus gattii serotype-C strains isolated in Bangalore, Karnataka, India

(2011) Massimo Cogliati et al.   MYCOSES

Cryptococcus gattii: a resurgent fungal pathogen

(2011) Vishnu Chaturvedi et al.   TRENDS IN MICROBIOLOGY

Heteroresistance of Cryptococcus gattii to Fluconazole

(2010) A. Varma et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

A prospective descriptive study of cryptococcal meningitis in HIV uninfected patients in Vietnam - high prevalence of Cryptococcus neoformans var grubii in the absence of underlying disease

(2010) Tran TH Chau et al.   BMC INFECTIOUS DISEASES

Prevalence of the VNIc genotype of Cryptococcus neoformans  in non-HIV-associated cryptococcosis in the Republic of Korea

(2010) Young Hwa Choi et al.   FEMS YEAST RESEARCH

Mixed Infections and In Vivo Evolution in the Human Fungal Pathogen Cryptococcus neoformans

(2010) M. Desnos-Ollivier et al.   mBio

Cryptococcus neoformans Overcomes Stress of Azole Drugs by Formation of Disomy in Specific Multiple Chromosomes

(2010) Edward Sionov et al.   PLoS Pathogens

Microbiological characteristics of clinical isolates of Cryptococcus neoformans in Taiwan: serotypes, mating types, molecular types, virulence factors, and antifungal susceptibility

(2009) S-J. Liaw et al.   CLINICAL MICROBIOLOGY AND INFECTION

Molecular Evidence That the Range of the Vancouver Island Outbreak ofCryptococcus gattiiInfection Has Expanded into the Pacific Northwest in the United States

(2009) Edmond J. Byrnes III et al.   JOURNAL OF INFECTIOUS DISEASES

Genotyping of MexicanCryptococcus neoformansandC. gattiiisolates by PCR-fingerprinting

(2009) L. R. Castañón Olivares et al.   MEDICAL MYCOLOGY

Epidemiology of cryptococcosis in Malaysia

(2009) S. T. Tay et al.   MYCOSES

First Reported Case of Cryptococcus gattii in the Southeastern USA: Implications for Travel-Associated Acquisition of an Emerging Pathogen

(2009) Edmond J. Byrnes et al.   PLoS One

When Primary Antifungal Therapy Fails

(2008) Marcio Nucci et al.   CLINICAL INFECTIOUS DISEASES

Genotype and mating type analysis ofCryptococcus neoformansandCryptococcus gattiiisolates from China that mainly originated from non-HIV-infected patients

(2008) Xiaobo Feng et al.   FEMS YEAST RESEARCH

Major Role for Amphotericin B–Flucytosine Combination in Severe Cryptococcosis

(2008) Françoise Dromer et al.   PLoS One